[go: up one dir, main page]

UY30300A1 - Compuestos triarílicos y sus derivados - Google Patents

Compuestos triarílicos y sus derivados

Info

Publication number
UY30300A1
UY30300A1 UY30300A UY30300A UY30300A1 UY 30300 A1 UY30300 A1 UY 30300A1 UY 30300 A UY30300 A UY 30300A UY 30300 A UY30300 A UY 30300A UY 30300 A1 UY30300 A1 UY 30300A1
Authority
UY
Uruguay
Prior art keywords
compounds
triary
derivatives
general formula
relates
Prior art date
Application number
UY30300A
Other languages
English (en)
Inventor
Chin Yung Ho
Remedios Hernandez-Perni
Yan Zhang
Svenja Burckhardt
Andrew Cansfield
Adeline Leformal
Kathryn Smelt
Jees Taylor
Cyrille Boussard
Jeremy Major
Mihiro Sunose
Richard John Harrison
Valerie Reader
Alison Reid
Francis Wilson
Original Assignee
Cellzome Uk Ltd
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36293499&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY30300(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cellzome Uk Ltd, Ortho Mcneil Pharm Inc filed Critical Cellzome Uk Ltd
Publication of UY30300A1 publication Critical patent/UY30300A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09—Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/30—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings
    • C07C57/38—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/52—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen
    • C07C57/58—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/56—Unsaturated compounds containing hydroxy or O-metal groups containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/33—Polycyclic acids
    • C07C63/331—Polycyclic acids with all carboxyl groups bound to non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62—Halogen-containing esters
    • C07C69/65—Halogen-containing esters of unsaturated acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se relaciona con compuestos que tienen la fórmula general (I) con compuestos que tienen la fórmula general (I) con las definiciones de X, Y, R1, R2, R3, R4, R9, R10 dadas a continuación y sus solvatos, hidratos, ésteres y sales farmacéuticamente aceptables. Más aún, la invención se relaciona con el uso de dichos compuestos para el tratamiento de la enfermedad de Alzheimer y con su uso para la modulación de la actividad y-secretasa-
UY30300A 2006-04-21 2007-04-20 Compuestos triarílicos y sus derivados UY30300A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06112934A EP1847524B1 (en) 2006-04-21 2006-04-21 Terphenyl derivatives for treatment of Alzheimer's disease

Publications (1)

Publication Number Publication Date
UY30300A1 true UY30300A1 (es) 2007-08-31

Family

ID=36293499

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30300A UY30300A1 (es) 2006-04-21 2007-04-20 Compuestos triarílicos y sus derivados

Country Status (34)

Country Link
US (1) US8106236B2 (es)
EP (2) EP1847524B1 (es)
JP (1) JP5422827B2 (es)
KR (1) KR101494906B1 (es)
CN (1) CN101484410B (es)
AR (1) AR060621A1 (es)
AT (1) ATE445586T1 (es)
AU (1) AU2007240382B2 (es)
BR (1) BRPI0710632A2 (es)
CA (1) CA2649845C (es)
CR (2) CR10376A (es)
CY (1) CY1109729T1 (es)
DE (1) DE602006009764D1 (es)
DK (1) DK1847524T3 (es)
EA (1) EA016908B1 (es)
ES (2) ES2333539T3 (es)
GE (1) GEP20115211B (es)
IL (2) IL194789A0 (es)
MA (1) MA30420B1 (es)
MX (1) MX2008013447A (es)
MY (1) MY148988A (es)
NO (1) NO20084516L (es)
NZ (1) NZ572999A (es)
PE (1) PE20080267A1 (es)
PL (1) PL1847524T3 (es)
PT (1) PT1847524E (es)
SI (1) SI1847524T1 (es)
SM (1) SMP200800062B (es)
TN (1) TNSN08414A1 (es)
TW (1) TWI435720B (es)
UA (1) UA95766C2 (es)
UY (1) UY30300A1 (es)
WO (1) WO2007124351A1 (es)
ZA (1) ZA200809857B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1847524B1 (en) 2006-04-21 2009-10-14 Cellzome Limited Terphenyl derivatives for treatment of Alzheimer's disease
MX2010004311A (es) * 2007-10-19 2010-05-03 Janssen Pharmaceutica Nv Productos intermedios de moduladores de gamma-secretasa.
EP2212277B1 (en) 2007-10-19 2016-08-31 Janssen Pharmaceutica, N.V. Amine linked modulators of y-secretase
NZ584716A (en) 2007-10-19 2011-12-22 Janssen Pharmaceutica Nv PIPERIDINYL AND PIPERAZINYL MODULATORS OF gamma-SECRETASE
CA2702959C (en) 2007-10-19 2016-07-26 Janssen Pharmaceutica Nv Carbon linked modulators of .gamma.-secretase
US20110092554A1 (en) * 2007-11-19 2011-04-21 Richard Chesworth 1,3,5 tri-subtituted benzenes for treatment of alzheimer's disease and other disorders
CN101896461A (zh) * 2007-12-13 2010-11-24 安姆根有限公司 γ分泌酶调节剂
RU2527177C2 (ru) 2007-12-20 2014-08-27 Энвиво Фармасьютикалз, Инк. Четырехзамещенные бензолы
AU2009224738A1 (en) * 2008-03-11 2009-09-17 Neurosearch A/S Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors
US7968725B2 (en) * 2008-07-22 2011-06-28 Janssen Pharmaceutica N.V. Pyridinyl modulators of γ-secretase
CA2828748C (en) * 2011-03-03 2019-06-25 Denovamed Inc. Antimicrobial / adjuvant compounds and methods
CN103012200B (zh) * 2011-09-20 2014-12-17 北京大学 具有β-分泌酶抑制功能的化合物及其制备方法与应用
WO2015109109A1 (en) 2014-01-15 2015-07-23 Forum Pharmaceuticals Inc. Fused morpholinopyrimidines and methods of use thereof
US9802927B2 (en) 2015-06-10 2017-10-31 Denali Therapeutics, Inc. Oxadiazine compounds and methods of use thereof
JP7656547B2 (ja) * 2019-05-15 2025-04-03 ケモセントリックス，インコーポレイティド Ｐｄ－ｌ１疾患治療用のトリアリール化合物
KR20230113770A9 (ko) * 2020-11-27 2024-03-25 미라이랩 바이오사이언스 인코퍼레이티드 고순도 β 니코틴아미드 모노뉴클레오티드(NMN) 및 그 제조 방법

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08325182A (ja) * 1995-05-31 1996-12-10 Fuji Yakuhin Kogyo Kk 置換テルフェニル誘導体とそれらを含有する抗血栓剤
FR2767525B1 (fr) * 1997-08-21 1999-11-12 Cird Galderma Derives biphenyliques substitues par un radical aromatique ou heteroaromatique et compositions pharmaceutiques et cosmetiques les contenant
JP2002544258A (ja) 1999-05-12 2002-12-24 ニューロサーチ、アクティーゼルスカブ イオンチャネル調節剤
AU5702201A (en) 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
EP1278734A2 (en) * 2000-04-24 2003-01-29 Merck Frosst Canada &amp; Co. Method of treatment using phenyl and biaryl derivatives as prostaglandin e inhibitors and compounds useful therefore
CN1277872C (zh) * 2001-02-20 2006-10-04 安德鲁斯街大学管理处 含金属的树状物
FR2838439B1 (fr) * 2002-04-11 2005-05-20 Sanofi Synthelabo Derives de terphenyle, leur preparation, les compositions pharmaceutqiues en contenant
AU2003298740A1 (en) * 2002-12-05 2004-06-30 Axys Pharmaceuticals, Inc. Cyanomethyl derivatives as cysteine protease inhibitors
GB0305918D0 (en) 2003-03-14 2003-04-23 Glaxo Group Ltd Novel compounds
EP1635829A1 (en) * 2003-04-30 2006-03-22 Merck Frosst Canada Ltd. 8-(3-biaryl)phenylquinoline phosphodiesterase-4-inhibitors
WO2005110963A1 (en) 2004-05-19 2005-11-24 Cellzome Ag (biphenyl-3-yl)-carboxylic acids and derivatives thereof and their use in therapy
GB0416508D0 (en) 2004-07-23 2004-08-25 Merck Sharp & Dohme Therapeutic agents
JP4987871B2 (ja) * 2005-08-15 2012-07-25 エフ．ホフマン−ラ ロシュ アーゲー Ｐ２ｘ３アンタゴニストとしてのピペリジン及びピペラジン誘導体
US8148572B2 (en) 2005-10-06 2012-04-03 Astrazeneca Ab Compounds
EP1847524B1 (en) 2006-04-21 2009-10-14 Cellzome Limited Terphenyl derivatives for treatment of Alzheimer's disease

Also Published As

Publication number Publication date
MX2008013447A (es) 2009-03-10
AU2007240382B2 (en) 2013-05-02
GEP20115211B (en) 2011-04-26
TNSN08414A1 (en) 2010-04-14
US8106236B2 (en) 2012-01-31
EA200802173A1 (ru) 2009-06-30
DK1847524T3 (da) 2010-01-11
EP1847524A1 (en) 2007-10-24
IL194789A0 (en) 2009-08-03
CR10376A (es) 2009-02-26
PE20080267A1 (es) 2008-05-16
PT1847524E (pt) 2009-12-18
HK1134923A1 (en) 2010-05-20
CN101484410B (zh) 2013-08-21
MA30420B1 (fr) 2009-05-04
KR101494906B1 (ko) 2015-02-24
JP5422827B2 (ja) 2014-02-19
BRPI0710632A2 (pt) 2011-08-23
EA016908B1 (ru) 2012-08-30
EP2016039B1 (en) 2012-08-01
PL1847524T3 (pl) 2010-03-31
TWI435720B (zh) 2014-05-01
ES2333539T3 (es) 2010-02-23
NZ572999A (en) 2012-06-29
IL194853A0 (en) 2009-08-03
CA2649845C (en) 2014-09-16
ES2392352T3 (es) 2012-12-10
SMP200800062B (it) 2009-07-14
WO2007124351A1 (en) 2007-11-01
AU2007240382A1 (en) 2007-11-01
KR20090024678A (ko) 2009-03-09
NO20084516L (no) 2009-01-13
US20070254957A1 (en) 2007-11-01
SMAP200800062A (it) 2008-11-19
EP2016039A1 (en) 2009-01-21
CN101484410A (zh) 2009-07-15
EP1847524B1 (en) 2009-10-14
SI1847524T1 (sl) 2010-01-29
MY148988A (en) 2013-06-28
ATE445586T1 (de) 2009-10-15
TW200810746A (en) 2008-03-01
CA2649845A1 (en) 2007-11-01
JP2009538275A (ja) 2009-11-05
DE602006009764D1 (de) 2009-11-26
AR060621A1 (es) 2008-07-02
CR10452A (es) 2009-02-23
ZA200809857B (en) 2009-08-26
UA95766C2 (ru) 2011-08-25
CY1109729T1 (el) 2014-09-10

Similar Documents

Publication Publication Date Title
UY30300A1 (es) Compuestos triarílicos y sus derivados
NI200700107A (es) (bifenil) ácidos carboxílicos y sus derivados
UY30426A1 (es) Derivados sustituidos del 3-(4-metoxi-fenil)-3h-isoindol-1-ilamina trifluoroacetado, sus sales o solvatos farmaceuticamente aceptables, formulaciones farmacéuticas y aplicaciones.
UY30301A1 (es) Ácidos bifenilcarboxílicos substituidos y sus derivados
UY31083A1 (es) Derivados de sulfoximinas para la inhibicion de b-secretasa
UY31084A1 (es) Compuestos de azaindol para la inhibicion de b-secretasa
UY31906A (es) Derivados de n-cicloalquil-3-fenilnicotinamida que inhiben pgds, sus composiciones, su uso para el tratamiento por ejemplo de afecciones alérgicas y respiratorias.
UY29927A1 (es) Derivados sustituidos de la 5-fenil-2-tioxo-imidazolin-4-ona y de la 5-fenil-2-amino-imidazolidin-4-ona y sus sales, composiciones y aplicaciones
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
CR9587A (es) Derivados de piridazina
CR9954A (es) Derivados de pirazina
UY30408A1 (es) Derivados sustituidos del acetato de 8-(4-metoxifenil)-2,3,4,8-tetrahidroimidazo-[1,5-a]-pirimidin-6-amina, composiciones farmacéuticas y aplicaciones
CR10250A (es) Derivados de amida y su aplicación para el tratamiento de enfermedades relacionadas con proteína-g
CO6321248A2 (es) Derivados de triazol utiles para el tratamiento de enfermedades
UY30025A1 (es) Derivados sustituidos de las 2-amino-5,6-dihidro pirimidin-4(3h)-onas y sus sales farmacéuticamente aceptables, composiciones farmacéuticas conteniéndolos y aplicaciones.
BRPI0507312A (pt) derivados de quinolina para uso como inibidores micobacterianos
ECSP088700A (es) Acidos 4-fenil-tiazol-5-carboxilicos y amidas de acidos 4-fenil-tiazol-5-carboxilicos como inhibidores de la plk1
UY28848A1 (es) Antagonistas de cgrp seleccionados, procedimientos para su preparación, y su empleo como medicamentos
UY27685A1 (es) Indolil-urea derivados de tienopiridinas útiles como agentes antiangiogénicos, y procedimientos para su uso
AR054129A1 (es) Derivados de 2, 6-quinolinilo, una preparacion farmaceutica que los contiene y su empleo en la fabricacion de medicamentos para el tratamiento de enfermedades dependientes de integrinas alfa4beta1 y/o alfa4beta7
AR063027A1 (es) Derivados de sulfonamida
ECSP099506A (es) Derivados de 2-quinolinona y 2 quinoxalinona y su utilización como agentes anti bacterianos
GT200600161A (es) Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de los trastornos psicoticos
UY30356A1 (es) Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos.
AR077429A1 (es) Compuestos hidroxiasenapina sus derivados y composiciones farmaceuticas que comprenden los mismos